Lataa...
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2011-03-01
|
| Sarja: | Therapeutic Advances in Neurological Disorders |
| Linkit: | https://doi.org/10.1177/1756285611403960 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|